Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 49.6B | 42.3B | 39.9B | 36.0B |
Cost of revenue | 20.6B | 22.9B | 15.6B | 13.9B |
Gross profit | 29.0B | 19.4B | 24.3B | 22.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 10.4B | 11.1B | 7.5B | 5.4B |
Other operating expenses | 21.3B | 12.1B | 17.5B | 16.2B |
Operating income | -12.4B | -11.6B | -8.8B | -6.9B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 410M | 321.5M | 255.6M | 230.5M |
Other income expense | — | — | — | — |
Pretax income | -12.0B | -10.8B | -8.0B | -6.3B |
Tax provision | 0 | 0 | 0 | 0 |
Net income | -12.0B | -10.8B | -8.0B | -6.3B |
Basic EPS | -5.0 | — | -3.5 | -2.8 |
Diluted EPS | -504 | — | -3.5 | -2.8 |
Basic average shares | 2.4B | — | 2.3B | 2.2B |
Diluted average shares | 2.4B | — | 2.3B | 2.2B |
EBITDA | -8.7B | -8.7B | -6.2B | -4.7B |
Net income from continuing op. | — | — | — | -6.3B |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |